• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,328.19 -516.33
( -0.66%)
Global Indices
Nasdaq
49,628.48 -303.12
(-0.61%)
Dow Jones
7,359.75 -26.37
(-0.36%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,288.99 -149.67
(-1.43%)
Forex
USD-INR
94.67 -0.51
(-0.53%)
EUR-INR
111.19 -0.10
(-0.09%)
GBP-INR
128.70 -0.19
(-0.14%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Lyka Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500259
INE933A01014
37.0210703
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LYKALABS
0
221.28
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales1143.791074.751135.72
Other Operating Income33.197.688.11
Other Income 10.6911.4312.34
Total Income1187.671093.861156.17
Total Expenditure 943.34905.79963.23
PBIDT244.33188.07192.94
Interest 42.4457.8157.73
PBDT201.89130.26135.21
Depreciation67.2263.4362.82
Tax31.4719.3719.02
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax103.2047.4653.37
Extra-ordinary Items -5.200.000.00
Adjusted Profit After Extra-ordinary item108.4047.4653.37
EPS (Unit Curr.)4.051.862.20
EPS (Adj) (Unit Curr.)4.051.862.20
Calculated EPS (Unit Curr.)4.051.862.20
Calculated EPS (Adj) (Unit Curr.)4.051.862.20
Calculated EPS (Ann.) (Unit Curr.)16.197.458.78
Calculated EPS (Adj) (Ann.) (Unit Curr.)16.197.458.78
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity25.4925.4924.31
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)21.3617.5016.99
PBDTM(%)17.6512.1211.91
PATM(%)9.024.424.70